Fat intake influences HbA1c-lowering effect in DPP4i therapy
(HealthDay)—For individuals with type 2 diabetes (T2D), fat intake may contribute to the deterioration of the hemoglobin A1c (HbA1c)-lowering effects in dipeptidyl peptidase-4 inhibitor (DPP4i) monotherapy, according to ...
Dec 4, 2017
0
0